Investing.com - Financial Markets Worldwide
🤔 This week: TSLA Q3 earnings report - is now the right time to buy the EV giant?Explore TSLA Data

Injective (INJ) Soars Past $12 Resistance, Will Bull Rally Persist?

Published 10/25/2023, 01:11 AM
Updated 10/25/2023, 01:15 AM
Injective (INJ) Soars Past $12 Resistance, Will Bull Rally Persist?

  • Injective (INJ) bulls breach the $12 resistance, marking a 20-month high in the last 24 hours.

  • New users flood Injective Network as Helix’s game-changing feature may have caused INJ’s price surge.

  • The $15 high may be the next target if bullish momentum breaches the resistance.

Injective (INJ) has catapulted to a significant milestone, breaching the $12 mark, as bullish momentum continues sweeping the crypto markets. Over the past ten days, this digital asset has been on an impressive winning streak.

Injective Network Welcomes a Wave of New Users

Injective’s recent meteoric rise can be attributed to a groundbreaking product feature unveiled by Helix, the decentralized exchange (DEX) built on the Injective Layer-1 blockchain. On October 19, Helix introduced pre-launch futures trading, allowing crypto enthusiasts to speculate on unreleased tokens before they hit the official market or exchange listings.

This move created a chain reac…

The post Injective (INJ) Soars Past $12 Resistance, Will Bull Rally Persist? appeared first on Coin Edition.

Read more on Coin Edition

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.